International Liver Congress

Meeting NewsVideo

VIDEO: WHO expert discusses lessons learned in the global hepatitis response

May 7, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Philippa Easterbrook, MD, senior scientist of the Global…
Meeting NewsVideo

VIDEO: Revita DMR procedure improves liver, cardiovascular parameters

May 3, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Harith Rajagopalan, MD, PhD, cofounder and CEO of Fractyl…
Meeting NewsVideo

VIDEO: Genfit promotes NASH awareness as equally important as therapy

April 30, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Dean Hum, PhD, chief scientific officer and chief operating…
Meeting NewsVideo

VIDEO: DAAs for youngest pediatric patients with HCV on the horizon

April 29, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Philippa Easterbrook, MD, senior scientist of the Global…
Meeting NewsVideo

VIDEO: Increased surveillance fuels hepatitis elimination in Africa

April 29, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Olufunmilayo Lesi, FWACP, FMCP, from the University of Lagos in…
Meeting NewsVideo

VIDEO: Seladelpar effective for PBC, to be studied in NASH

April 27, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Sujal Shah, MS, MBA, president and CEO of CymaBay Therapeutics…
Meeting NewsVideo

VIDEO: First step to HBV cure is ‘understanding the virus’

April 26, 2019
In this exclusive video from the 2019 International Liver Congress, Anuj Gaggar, MD, PhD, vice president of clinical research in liver diseases at…
Meeting NewsVideo

VIDEO: Diabetes drug ‘very logical’ choice for combination therapy in NASH

April 26, 2019
VIENNA — In this exclusive video from the 2019 International Liver Congress, Rob Myers, MD, vice president of the liver diseases therapeutic…
Meeting News

Exercise intervention for NAFLD shows promise if adherence maintained

April 25, 2019
VIENNA — Patients with nonalcoholic fatty liver disease who underwent a 12-week aerobic exercise intervention showed significant improvements…
Meeting NewsVideo

VIDEO: Janssen HBV pipeline focuses on ‘increasing functional cure’ rates

April 24, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, James Merson, PhD, global therapeutic area head for infectious…